NCT06814288View on ClinicalTrials.gov

The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

March 1, 2025

Conditions
Keloid Scars
Interventions
DRUG

Botulinum toxin A

Twenty keloid patients will be injected botulinum toxin A intralesional every 4 weeks.

DRUG

Triamcinolone Acetonide

Twenty keloid patients will be injected triamcinolone acetonide intralesional every 4 weeks.

Trial Locations (1)

20161

Hasan Sadikin General Hospital, Bandung

All Listed Sponsors
lead

Universitas Padjadjaran

OTHER

NCT06814288 - The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment | Biotech Hunter | Biotech Hunter